Apricot Capital logo

Apricot Capital

Asia, Shanghai, China, Shanghai

Description

Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry.

Investor Profile

Apricot Capital has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series D, Seed rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series Unknown (33%)
  • Series D (33%)
  • Seed (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
  • Medical
  • Medical Device
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Apricot Capital frequently co-invest with?

NS
North America, New York, United States, New York
Co-Investments: 1
Sinopharm Holding
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Fosun Pharma
Asia, Shanghai, China, Shanghai
Co-Investments: 1
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
CCB Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BOCOM International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Humanwell
Asia, Hubei, China, Wuhan
Co-Investments: 1
Everbright
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
CI
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
HOPU Investment Management Company
Asia, Hebei, China, Xicheng
Co-Investments: 1

What are some of recent deals done by Apricot Capital?

Excalipoint Therapetics

Admiralty, Hong Kong Island, Hong Kong

Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.

BiotechnologyHealth CareLife ScienceTherapeutics
SeedMar 18, 2026
Amount Raised: $27,700,000
QL Biopharma

Changping, Beijing, China

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

BiopharmaHealth CareMedical
Series CMar 2, 2026
Amount Raised: $72,780,204
Zhiran Medical

Beijing, Beijing, China

Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders.

Health CareMedicalNeuroscience
Series AFeb 11, 2026
Amount Raised: $43,397,127
Microtide Biotechnology

Shanghai, Shanghai, China

Microtide Biotechnology an innovative company in the field of in vivo cell therapy.

Series AFeb 2, 2026
Neowise

Suzhou, Jiangsu, China

XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.

BiotechnologyHealth CarePharmaceutical
Series BJan 26, 2026
Amount Raised: $28,722,014
Vibrant

Guangzhou, Guangdong, China

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines.

Artificial Intelligence (AI)Health CareInformation Technology
Series UnknownJan 12, 2026
Amount Raised: $61,000,000
LyncBio Therapeutics

Shanghai, Shanghai, China

LyncBio Therapeutics is a medical company that provides treatments, research, and toxicology studies about intestinal inflammation.

BiotechnologyHealth CareMedical
SeedDec 25, 2025
Amount Raised: $14,273,684
Microtide Biotechnology

Shanghai, Shanghai, China

Microtide Biotechnology an innovative company in the field of in vivo cell therapy.

AngelNov 5, 2025
Amount Raised: $14,031,543
Vibrant

Guangzhou, Guangdong, China

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines.

Artificial Intelligence (AI)Health CareInformation Technology
Series AAug 25, 2025
Excalipoint Therapetics

Admiralty, Hong Kong Island, Hong Kong

Excalipoint Therapeutics is a Private limited company.

Therapeutics
Series AAug 4, 2025
Amount Raised: $41,000,000

Find More Investors Like Apricot Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Apricot Capital | Pipeseed